. Fabrication process for preparing a multilevel microfluidic device for cell migration studies. (a) Adhesive tape was cut into a desired design for each level using a cutting plotter and the sections stacked to construct multilevel structures. (b) A 10:1 mixture of PDMS prepolymer and curing agent was poured onto the tape master, followed by curing in an oven at 65°C for 2 h. (c) The PDMS was peeled off from the master, diced into individual chips, and holes were punched. The PDMS mold was bonded onto a glass coverslip after oxygen plasma treatment of both surfaces, followed by sterilization with 70% ethanol and UV exposure for 30 min. (d) A collagen gel containing DCs was injected into the shallowest main channel, followed by polymerization in a 5% CO2, 37°C incubator for 50 min. (e) Then, 1% agarose solution was injected into the channels adjacent to the main channel, followed by gelation of the agarose solution at room temperature. (f) Culture medium with CCL19 (3 μg/ml) or culture medium only was loaded into the individual chamber, to generate the linear concentration gradient of CCL19 across the collagen gel. FBS, EGF (3.3 ng/ml), hydrocortisone (83 ng/ml), insulin (1.67 µg/ml) and 1% antibioticantimycotic solution. **P < 0.01. Representative uncropped western blot images of MAP kinase molecules, JNK, c-Jun, ERK or p-38, in mDC only, mDC-MCF-7, mDC-MDA-MB-231 or mDC-MDA-MB-436 described in Fig.   3a ,b. p=phosphorylated, T=total.
9 Figure S8 . Full-length Western blot images for Fig. 3g and Fig. 4a (a-b) Representative uncropped western blot images of GTP-RhoA in mDC only or mDC-MDA-MB-231 described in Fig. 3g (a) or of JNK and c-Jun molecules in mDC only or mDC-MDA-MB-231 in the presence of a JNK inhibitor described in Fig. 4a (b) . p=phosphorylated, T=total.
